Location History:
- Ville Mont-Royal, CA (2001)
- Mont-Royal, CA (2001 - 2004)
Company Filing History:
6 out of 62 
1 out of 1,536 
Years Active: 2001-2004
Title: The Innovations of Robert Déziel
Introduction
Robert Déziel is a notable inventor based in Mont-Royal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-nucleoside reverse transcriptase inhibitors. With a total of 7 patents to his name, Déziel's work has had a considerable impact on medical research and treatment options.
Latest Patents
Among his latest patents, Robert Déziel has focused on non-nucleoside reverse transcriptase inhibitors. These compounds play a crucial role in the treatment of viral infections, particularly HIV. His innovative approaches in this area have opened new avenues for therapeutic interventions.
Career Highlights
Throughout his career, Déziel has worked with prominent companies such as Boehringer Ingelheim (Canada) Ltd. and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to collaborate with leading experts in the pharmaceutical industry and contribute to groundbreaking research.
Collaborations
Robert Déziel has had the opportunity to work alongside talented individuals such as Jeffrey O'Meara and William W. Ogilvie. These collaborations have enriched his research and fostered a dynamic exchange of ideas within the field.
Conclusion
In summary, Robert Déziel is a distinguished inventor whose work in non-nucleoside reverse transcriptase inhibitors has made a significant impact in the pharmaceutical industry. His contributions continue to influence medical research and treatment strategies.